Bimeda Launches XylaMed, a Sedative and Analgesic for Use in Horses

Newsdate Thu 14 August 2014 – 7:20 am

Location: OAKBROOK TERRACE, Illinois

Now available from Bimeda, XylaMed™(xylazine), a sedative and analgesic for use in horses has been approved by the FDA.

Calming horses and protecting vets and handlers

Calming horses and protecting vets and handlers

XylaMed™(xylazine), a sedative and analgesic for use in horses has been approved by the FDA and is now available from Bimedia to facilitate handling of aggressive or nervous animals, reducing physical stress and risk to both animal and practitioner.

This product will be available through Bimeda’s nationwide network of authorized animal health veterinary product distributors.

Veterinarians utilizing XylaMed™ for charitable work may contact Bimeda at info@bimedaUS.com for assistance.

XYLAMED’S Benefits:

  • Sedation - Facilitates the handling of aggressive or nervous animals, reducing physical stress and risk to both animal and practitioner.
  • Successfully used in conducting diagnostic procedures, Orthopedic procedures, Dental procedures & minor surgical procedures of short duration.
  • Therapeutic medication for relief of pain following injury or surgery.
  • Preanesthetic to general anesthesia or in conjunction with local anesthetics during major surgical procedures.

For complete product labeling and more information visit www.BimedaUS.com

CAUTION

Federal law restricts this drug to use by or on the order of a licensed veterinarian..

PRECAUTIONS

Careful consideration should be given before administering to horses with significantly depressed respiration, severe pathologic heart disease, advanced liver or kidney disease, severe endotoxic or traumatic shock, or stress conditions such as extreme heat, cold, high altitude, or fatigue.

Do not use XylaMed™ in conjunction with tranquilizers. Analgesic effect is variable, and depth should be carefully assayed prior to surgical/clinical procedures. Variability of analgesia occurs most frequently at the distal extremities of horses. In spite of sedation, the practitioner and handlers should proceed with caution since defense reactions may not be diminished.

About Bimeda

Bimeda is a global manufacturer and marketer of a variety of unique and generic animal health pharmaceutical product dosage forms produced in seven manufacturing plants in Brazil, Canada, Ireland, Kenya, U.K and the USA. Additional information regarding Bimeda and their products is available by visiting www.bimeda.com or calling 1-888-524-6332.

About the Author

Flossie Sellers

Author picture

As an animal lover since childhood, Flossie was delighted when Mark, the CEO and developer of EquiMed asked her to join his team of contributors.

She enrolled in My Horse University at Michigan State and completed a number of courses in everything related to horse health, nutrition, diseases and conditions, medications, hoof and dental care, barn safety, and first aid.

Staying up-to-date on the latest developments in horse care and equine health is now a habit, and she enjoys sharing a wealth of information with horse owners everywhere.

Subscribe